Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
Division of Biomedical Informatics, Department of Medicine, University of California, San Diego, San Diego, California.
Cancer Res. 2021 Feb 15;81(4):1123-1134. doi: 10.1158/0008-5472.CAN-20-0335. Epub 2020 Dec 8.
Cancer screening and early detection efforts have been partially successful in reducing incidence and mortality, but many improvements are needed. Although current medical practice is informed by epidemiologic studies and experts, the decisions for guidelines are ultimately . We propose here that quantitative optimization of protocols can potentially increase screening success and reduce overdiagnosis. Mathematical modeling of the stochastic process of cancer evolution can be used to derive and optimize the timing of clinical screens so that the probability is maximal that a patient is screened within a certain "window of opportunity" for intervention when early cancer development may be observable. Alternative to a strictly empirical approach or microsimulations of a multitude of possible scenarios, biologically based mechanistic modeling can be used for predicting when best to screen and begin adaptive surveillance. We introduce a methodology for optimizing screening, assessing potential risks, and quantifying associated costs to healthcare using multiscale models. As a case study in Barrett's esophagus, these methods were applied for a model of esophageal adenocarcinoma that was previously calibrated to U.S. cancer registry data. Optimal screening ages for patients with symptomatic gastroesophageal reflux disease were older (58 for men and 64 for women) than what is currently recommended (age > 50 years). These ages are in a cost-effective range to start screening and were independently validated by data used in current guidelines. Collectively, our framework captures critical aspects of cancer evolution within patients with Barrett's esophagus for a more personalized screening design. SIGNIFICANCE: This study demonstrates how mathematical modeling of cancer evolution can be used to optimize screening regimes, with the added potential to improve surveillance regimes. GRAPHICAL ABSTRACT: http://cancerres.aacrjournals.org/content/canres/81/4/1123/F1.large.jpg.
癌症筛查和早期检测工作在降低发病率和死亡率方面取得了一定的成功,但仍有许多改进的空间。尽管当前的医学实践是基于流行病学研究和专家意见,但指南的决策最终还是要考虑患者的个人情况。在这里,我们提出,定量优化方案可以提高筛查的成功率并减少过度诊断。通过对癌症进化的随机过程进行数学建模,可以推导出并优化临床筛查的时机,使患者在早期癌症发展可观测的“机会窗口”内被筛查的概率最大化。除了严格的经验方法或对多种可能情况的微观模拟外,还可以使用基于生物学的机制建模来预测何时最佳进行筛查并开始适应性监测。我们引入了一种使用多尺度模型来优化筛查、评估潜在风险和量化相关医疗成本的方法。作为 Barrett 食管的案例研究,我们将这些方法应用于先前根据美国癌症登记数据校准的食管腺癌模型。对于有症状的胃食管反流病患者,最佳筛查年龄(男性为 58 岁,女性为 64 岁)比目前建议的年龄(> 50 岁)要大。这些年龄在开始筛查的成本效益范围内,并且通过当前指南中使用的数据进行了独立验证。总体而言,我们的框架捕获了 Barrett 食管患者中癌症进化的关键方面,以实现更个性化的筛查设计。意义:本研究表明,如何使用癌症进化的数学模型来优化筛查方案,并有可能改善监测方案。